UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of hepatology, ISSN 0168-8278, 2016, Volume 66, Issue 2, pp. 282 - 287
Gastroenterology and Hepatology | HCV therapy | Spontaneous clearance | HIV-HCV coinfection | Acute hepatitis C | HCV reinfection | SVR | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Hepacivirus - isolation & purification | Communicable Disease Control - statistics & numerical data | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | HIV Infections - epidemiology | HIV Infections - virology | Humans | Middle Aged | Europe - epidemiology | Male | Coinfection - epidemiology | Incidence | Homosexuality, Male | Hepatitis C - epidemiology | Hepatitis C - virology | HIV Seropositivity - epidemiology | Adult | Female | HIV Infections - drug therapy | Hepatitis C virus | HIV (Viruses) | HIV patients | Mens health | Hepatitis | Risk groups | Human immunodeficiency virus--HIV | Sex | Interferon | Hepatitis C | Morbidity | Ribavirin | Index Medicus
Journal Article
HIV medicine, ISSN 1464-2662, 2018, Volume 19, Issue 5, pp. 309 - 315
ART | comorbidities | HIV | opportunistic diseases | coinfections | European AIDS Clinical Society guidelines | HCV | antiretroviral treatment | HBV | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Liver diseases | Comorbidity | Vaccination | Practice guidelines (Medicine) | HIV patients | HIV (Viruses) | Tenofovir | Highly active antiretroviral therapy | Tuberculosis | Transplantation of organs, tissues, etc | Respiratory tract diseases | Drug therapy | Hepatitis C virus | Hepatitis C | Health aspects | Distance learning | Toxicity | Liver | Lung transplantation | Switches | Viruses | Transplantation | Guidelines | Hepatitis | Fatty liver | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Older people | Drug interaction | Antiviral agents | Medical treatment | Lung diseases | Drug interactions | Antiretroviral therapy | Pregnancy | Geriatrics | Computer assisted instruction--CAI | Index Medicus | European AIDS Clinical Society (EACS) Guideline
Journal Article
AIDS (London), ISSN 0269-9370, 07/2019, Volume 33, Issue 9, pp. 1455 - 1465
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Tenofovir | Medical research | Safety and security measures | Analysis | Clinical trials | Medicine, Experimental | Dosage and administration | Kidney diseases | Risk factors | Index Medicus | AIDS/HIV | drug safety biomarkers | Clinical Science | HIV | proximal renal tubular dysfunction | adverse drug event | tenofovir disoproxil fumarate | renal fanconi syndrome | HAART
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 08/2020
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 06/2020
Journal Article
MMW Fortschritte der Medizin, ISSN 1438-3276, 04/2004, Volume 146 Spec No 1, pp. 18 - 19
HIV Protease Inhibitors - adverse effects | Pyridines - administration & dosage | Drug Administration Schedule | Humans | Drug Approval | HIV Protease Inhibitors - administration & dosage | Oligopeptides - adverse effects | Pyridines - adverse effects | Atazanavir Sulfate | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Drug Therapy, Combination | Delayed-Action Preparations | Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 11/2020, Volume 222, Issue 9, pp. S782 - S788
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 4/2008, Volume 61, Issue 4, pp. 914 - 918
Pharmacogenetics | Drug disposition | Metabolism | Pharmacokinetics | NNRTIs | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Multivariate Analysis | Oxidoreductases, N-Demethylating - genetics | Age Factors | Reverse Transcriptase Inhibitors - blood | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Male | Nevirapine - therapeutic use | Chromatography, High Pressure Liquid | Nevirapine - blood | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - pharmacokinetics | Polymerase Chain Reaction | Aged, 80 and over | Adult | Benzoxazines - blood | Female | Reverse Transcriptase Inhibitors - therapeutic use | Body Mass Index | Gene Frequency | European Continental Ancestry Group | Benzoxazines - therapeutic use | Polymorphism, Genetic | HIV Infections - drug therapy | Aged | African Continental Ancestry Group | Nevirapine - pharmacokinetics | Cytochrome P-450 CYP2B6 | Genotype & phenotype | Human immunodeficiency virus--HIV | Whites | Blacks | Bioavailability | Antiviral drugs | Polymorphism | Index Medicus | pharmacokinetics | drug disposition | metabolism | pharmacogenetics
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 9/2005, Volume 192, Issue 6, pp. 992 - 1002
HIV/AIDS | Highly active antiretroviral therapy | Coinfection | RNA | HIV | Liver | AIDS | Infections | Hepacivirus | HIV 1 | Diseases | Fundamental and applied biological sciences. Psychology | Miscellaneous | Viral hepatitis | Infectious diseases | Microbiology | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Virology | HIV Infections - virology | Humans | Middle Aged | Risk Factors | Male | RNA, Viral - blood | CD4 Lymphocyte Count | Disease Progression | Antiretroviral Therapy, Highly Active | HIV Infections - immunology | Hepatitis C - immunology | HIV-1 - isolation & purification | Hepatitis C Antibodies - blood | Hepatitis C - mortality | HIV Infections - complications | Survival Analysis | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Hepatitis C - complications | Cohort Studies | Antiviral agents | Dosage and administration | Liver diseases | Diagnosis | Drug therapy | Hepatitis C | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 09/2020, Volume 71, Issue 6, pp. 1379 - 1389
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9835, pp. 2429 - 2438
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV-1 | Humans | Middle Aged | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Anti-HIV Agents - administration & dosage | Tenofovir | Atazanavir Sulfate | Adult | Female | Emtricitabine | Adenine - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Ritonavir - administration & dosage | Deoxycytidine - administration & dosage | Adenine - administration & dosage | Organophosphonates - administration & dosage | Quinolones - administration & dosage | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Patient outcomes | Dosage and administration | Research | Comparative analysis | Drug therapy | HIV infection | Anti-HIV agents | Antiretroviral drugs | Bone density | Pharmaceutical industry | Human immunodeficiency virus--HIV | Pneumonia | Laboratories | Ritonavir | Liver | Infections | Drug resistance | Evidence-based medicine | Hepatitis | Randomization | All terrain vehicles | Creatinine | Integrase | Data processing | Proteinase inhibitors | Behavior disorders | Ribonucleic acid--RNA | Patients | Cholesterol | Glomerular filtration rate | Protease inhibitors | Interactive systems | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2019, Volume 393, Issue 10189, pp. 2428 - 2438
Prospective Studies | Humans | Middle Aged | yes | Anti-HIV Agents/therapeutic use | Male | HIV Seropositivity/transmission | Viral Load | Antiretroviral Therapy, Highly Active | Homosexuality, Male | Unsafe Sex | Adult | Condoms | Sexual Partners | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | HIV Seropositivity - transmission | Anti-HIV Agents - therapeutic use | HIV patients | Disease transmission | HIV (Viruses) | Gay couples | Risk factors | Therapy | Sexually transmitted diseases--STD | Prophylaxis | Sex | Risk | Partnerships | Infections | Phylogeny | Incidence | Mathematical analysis | Antiretroviral agents | Human immunodeficiency virus--HIV | Drug therapy | Anal sex | Antiretroviral drugs | Sexual behavior | Health risks | Exposure | Ribonucleic acid--RNA | Seroconversion | Antiretroviral therapy | Data collection | Gays & lesbians | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article